Rebecca works at UCL/UCLH as a clinical senior lecturer and consultant medical oncologist joining in October 2009 to develop the early phase clinical trial and translational research programme in solid tumours with a specialist focus in gynaecological malignancy (ovarian, endometrial and cervical cancers).
Rebecca obtained a BSc at St Andrew’s University before qualifying from Manchester University with MBChB in 1995. As an undergraduate, she was awarded an Erasmus scholarship to complete part of her clinical training at the University of Lausanne (Switzerland) and studied cardiology at Harvard University (US) during her elective. She undertook her specialist training in medical oncology at The Royal Marsden Hospital and developed a specialist interest at an early stage in her career to the application of novel therapeutics in cancer.
She pursued a CRUK-funded research fellowship at the Institute of Cancer Research, Sutton and Drug Development Unit at The Royal Marsden Hospital investigating the preclinical and clinical pharmacology of HDAC inhibitors and was awarded her PhD in 2009. Subsequently, Rebecca spent a year as a senior fellow on the Drug Development Unit at the Royal Marsden Hospital gaining specialist experience in the design and conduct of early phase clinical trials.
Through her work as part of the core gynaecological oncology team and the clinical research facility at UCLH and UCL Cancer Institute, Rebecca aims to develop a comprehensive portfolio of cutting-edge early phase trials and translational research studies to identify and evaluate innovative treatment strategies for cancer, particularly gynaecologic malignancies. She has already received grant-funding, including an ECMC award, for translational projects in endometrial and ovarian cancer and is PI for a number of early phase studies open or due to open over the next 6 months. She teaches on MSc, PhD and medical degree courses for undergraduate and postgraduate students.